C12Y 103/99004
3-oxosteroid 1-dehydrogenase
Official title: 3-Oxosteroid 1-dehydrogenase (1.3.99.4)
C12Y103/99004 (3-oxosteroid 1-dehydrogenase) appears on 4 US grants and 8 published applications in this corpus.
Search patents in C12Y- Granted patents
- 4
- Published applications
- 8
- Assignees
- 8
- Inventors
- 25
- Latest grant
- 19 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2020 | 0 | 1 |
| 2021 | 0 | 2 |
| 2022 | 0 | 1 |
| 2023 | 1 | 1 |
| 2024 | 0 | 3 |
| 2025 | 0 | 0 |
| 2026 | 3 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Biotechnological optimization of microorganisms for the 1,2-dehydrogenation of steroids19 May 2026US 12,630,853 B2Euroapi France
- Targeted expression of microbial cholesterol catalysis genes reduces excess lipid10 Feb 2026US 12,544,402 B2Repair Biotechnologies, Inc.
- Enabling cholesterol catabolism in mammalian cells lacking same10 Feb 2026US 12,545,918 B2University of South Alabama Foundation for Research and Commercialization
- Compostions and methods for enabling cholesterol catabolism in human cells28 Mar 2023US 11,612,619 B2National Institute of Health (NIH), U.S. Dept. Of Health and Human Services (DHHS), U.S. Government
- Genetically modified organisms for the production of steroid derivatives28 Mar 2024US 2024/0102073 A1Sandhill One, LLC
- Hepatocellular carcinoma treatments, prophylactic therapies, and compositions for use therewith7 Mar 2024US 2024/0075108 A1Repair Biotechnologies, Inc.
- Enhancing mitochondrial-based flow and catabolism of cholesterol15 Feb 2024US 2024/0050592 A1Repair Biotechnologies, Inc.
- Enabling cholesterol catabolism in human cells24 Aug 2023US 2023/0263829 A1University of South Alabama Foundation for Research and Commercialization
- Biotechnological optimization of microorganisms for the 1,2-dehydrogenation of steroids5 May 2022US 2022/0136029 A1Sanofi
Most cited
By later US patents